Kura Oncology
$9.29
23
+$0.04+0.43% Tuesday 20:00
Statistics
Day High
9.42
Day Low
9.04
52W High
12.14
52W Low
5.54
Volume
665,951
Avg. Volume
-
Mkt Cap
808.4M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
30JulExpected
Expected EPS
-0.973494
Actual EPS
N/A
Financials
-322.89%Profit Margin
Unprofitable107.77MRevenue
-347.97MNet Income
Analyst Ratings
26.71Average Price Target
The highest estimate is 40.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow KURA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap163.4B
Incyte
INCY
Mkt Cap19.36B
Merck
MRK
Mkt Cap277.02B
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Novartis
NVS
Mkt Cap279.67B
AMGEN
AMGN
Mkt Cap178B
Pfizer
PFE
Mkt Cap149.77B
Roche
RHHBY
Mkt Cap328.49B
About
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Show more...
CEO
Dr. Troy Edward Wilson J.D., Ph.D.
Employees
192
Country
United States
ISIN
US50127T1097
Listings
0 Comments
Share your thoughts
FAQ
What is Kura Oncology stock price today?▼
The current price of KURA is $9.29 USD — it has increased by +0.43% in the past 24 hours. Watch Kura Oncology stock price performance more closely on the chart.
What is Kura Oncology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Kura Oncology stocks are traded under the ticker KURA.
Is Kura Oncology stock price growing?▼
KURA stock has risen by +6.17% compared to the previous week, the month change is a +9.42% rise, over the last year Kura Oncology has showed a +60.45% increase.
What is Kura Oncology market cap?▼
Today Kura Oncology has the market capitalization of 808.4M
When is the next Kura Oncology earnings date?▼
Kura Oncology is going to release the next earnings report on May 12, 2026.
What were Kura Oncology earnings last quarter?▼
KURA earnings for the last quarter are -0.92 USD per share, whereas the estimation was -0.64 USD resulting in a -43.98% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kura Oncology revenue for the last year?▼
Kura Oncology revenue for the last year amounts to 107.77M USD.
What is Kura Oncology net income for the last year?▼
KURA net income for the last year is -347.97M USD.
How many employees does Kura Oncology have?▼
As of May 06, 2026, the company has 192 employees.
In which sector is Kura Oncology located?▼
Kura Oncology operates in the Health & Wellness sector.
When did Kura Oncology complete a stock split?▼
Kura Oncology has not had any recent stock splits.
Where is Kura Oncology headquartered?▼
Kura Oncology is headquartered in San Diego, United States.